Eucrisa is a Topical Ointment in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Crisaborole.
| Product ID | 55724-211_3b007d27-fedd-49d7-9f0a-5d2e8adbb0ec |
| NDC | 55724-211 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Eucrisa |
| Generic Name | Crisaborole |
| Dosage Form | Ointment |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2017-01-30 |
| Marketing Category | NDA / NDA |
| Application Number | NDA207695 |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Substance Name | CRISABOROLE |
| Active Ingredient Strength | 20 mg/g |
| Pharm Classes | Phosphodiesterase 4 Inhibitor [EPC],Phosphodiesterase 4 Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2017-01-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA207695 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | GM |
| Marketing Start Date | 2017-01-30 |
| Marketing Category | NDA |
| Application Number | NDA207695 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2017-01-30 |
| Marketing Category | NDA |
| Application Number | NDA207695 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2017-01-30 |
| Marketing Category | NDA |
| Application Number | NDA207695 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | GM |
| Marketing Start Date | 2017-01-30 |
| Ingredient | Strength |
|---|---|
| CRISABOROLE | 20 mg/g |
| SPL SET ID: | 609b77de-1ca3-4783-b8f5-01a9c0f1d77d |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() EUCRISA 86660378 5191867 Live/Registered |
Anacor Pharmaceuticals, Inc. 2015-06-12 |